Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development

Contributed by: Business Wire

Logo

Business Wire logo

Tags

Other Professional Services
Data Management
Manufacturing
Technology
Consulting
Pharmaceutical
Professional Services
Artificial Intelligence
Clinical Trials
Science
Biotechnology
Software
Health
Engineering
Research
Certara

More Like This

CRO Leadership Awards 2024: Capabilities (Graphic: Business Wire)

Altasciences Receives 2024 CRO Leadership Award for Capabilities

From left to right: Nasir Egal (General Manager, CDMO Services); Marie-Hélène Raigneau (Chief Executive Officer); Anuji Abraham (Senior Director, Pharmaceutical Development, CDMO Services); Robert Sabelli (Co-Chief Operating Officer); Cathy Konidas (Chief Administrative Officer)

Altasciences Completes Expansion of Research and Development Laboratory in Harleysville, Pennsylvania

Business Wire logo

Altasciences’ Commitment to Supporting Pharma and Biotech With Comprehensive Bioanalytical Services

Business Wire logo

CORRECTING and REPLACING Altasciences Supports Metsera in Their Early-Stage Clinical Trials for Obesity

Business Wire logo

Altasciences and Evidence Matters Advance AI-Driven Drug Development With Nonclinical Automation Breakthrough

Business Wire logo

Altasciences and VoxCell BioInnovation Announce Strategic Collaboration to Advance Preclinical Drug Development

Business Wire logo

Veristat to Acquire Certara’s Regulatory and Medical Writing Business

Business Wire logo

Altasciences and Evidence Matters Announce Strategic Collaboration to Advance AI-Enhanced Text Engineering for Regulatory Writing in Life Sciences

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2026

Terms of Use

Privacy Policy

Contact Us